Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewRevenueFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 15.18% institutional investors, 43.55% insiders, and 41.27% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 3.01% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.50% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma15.18%43.55%41.27%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de642.98K3.01%$4.80M
Vanguard group325.30K1.89%$1.76M
Iridian asset management llc/ct372.72K1.74%$2.78M
Baldwin brothers llc/ma350.46K1.64%$2.62M
Blackrock83.41K0.50%$528.00K
Geode capital management79.24K0.46%$428.78K
Goldman sachs group61.57K0.37%$389.74K
Northern trust49.83K0.30%$315.40K
Marshall wace, llp63.61K0.30%$475.19K
Forbes j m & co llp59.00K0.28%$440.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Iridian asset management llc/ct372.72K0.96%$2.78M
Baldwin brothers llc/ma350.46K0.18%$2.62M
Forbes j m & co llp59.00K0.04%$440.73K
Austin wealth management20.13K0.02%$140.07K
Gsa capital partners llp34.75K0.01%$188.00K
Baxter bros15.00K0.01%$112.05K
Nations financial group inc, /ia/ /adv13.00K0.01%$97.11K
Oppenheimer25.00K0.00%$135.25K
Edmond de rothschild15.17K0.00%$82.07K
Marshall wace, llp63.61K0.00%$475.19K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de642.98K0.00%574.50K
Iridian asset management llc/ct372.72K0.96%118.75K
Goldman sachs group61.57K0.00%61.57K
Oppenheimer25.00K0.00%25.00K
Marshall wace, llp63.61K0.00%24.74K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
State street15.30K--114.08K
Jane street group---42.30K
Millennium management29.70K0.00%-38.80K
Omers administration---32.88K

New Positions

HolderShares% AssetsChangeValue
Goldman sachs group61.57K0.00%61.57K$389.74K
Oppenheimer25.00K0.00%25.00K$135.25K
Citadel advisors14.94K-14.94K$94.55K
Macquarie group355.00-355.00$2.25K
Bnp paribas arbitrage, snc115.00-115.00$622.00

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nbc securities-5.00
Nisa investment advisors-12.00
Gamma investing-25.00
Point72 (difc)-49.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20254932.43%3,242,70858.40%1514.40%3650.00%7133.33%
Mar 31, 20253719.35%2,047,14054.99%1017.47%2414.29%3-62.50%
Dec 31, 202430-3.23%1,298,77823.77%720.32%2053.85%8-27.27%
Sep 30, 202431-18.42%1,049,389-12.85%611.52%14-44.00%11-
Jun 30, 202438-5.00%1,204,111-22.91%79.04%2513.64%11-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv357.63K1.50%-7.89K
iShares Russell 2000 ETF255.70K1.07%-4.83K
Vanguard Institutional Extnd Mkt Idx Tr130.84K0.55%-64.53K
iShares Russell 2000 Growth ETF108.20K0.45%-
Fidelity Extended Market Index62.77K0.27%-164.00
Vanguard Russell 2000 ETF62.02K0.26%-3.50K
State St Russell Sm Cap® Indx SL Cl I45.10K0.19%-
Schwab Small Cap Index32.38K0.14%-
NT R2000 Index Fund - NL31.13K0.13%31.13K
iShares Micro-Cap ETF29.93K0.13%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 20, 2025Mosseri Marlio Charles-Buy$44.77K
Jun 17, 2025Mosseri Marlio Charles-Buy$43.79K
Jun 18, 2025Mosseri Marlio Charles-Buy$225.75K
May 12, 2025Mosseri Marlio Charles-Buy$171.66K
May 09, 2025Mosseri Marlio Charles-Buy$48.43K

Insider Transactions Trends


DateBuySell
2025 Q217-
2025 Q11-
2024 Q461
2024 Q3--
2024 Q24-

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 15.18%, followed by 43.55% insiders and 41.27% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 306.59%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Blackrock funding, inc. /de (642.98K shares, 3.01%), Vanguard group (325.3K shares, 1.89%), and Iridian asset management llc/ct (372.72K shares, 1.74%). Together, they hold 6.64% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Iridian asset management llc/ct is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 372.72K Nuvectis Pharma shares, valued at 2.78M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 1.50% of its total shares outstanding invested in 357.63K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools